EU Drug Agency Begins Rolling Review of Sanofi Covid-19 Vaccine Candidate
20 Julio 2021 - 10:39AM
Noticias Dow Jones
By Joshua Kirby
The European Union's medicines authority has begun a rolling
review of French pharmaceutical company Sanofi SA's Covid-19
vaccine candidate, Vidprevtyn, after preliminary study results
suggest it could be effective in protecting against the virus.
The European Medicines Agency's human medicines committee, or
CHMP, will evaluate data as they become available to see if the
benefits of Vidprevtyn outweigh its potential risks, the agency
said on Tuesday. The rolling review will continue until enough
evidence is available for a formal marketing-authorization
application.
The EMA said it can't estimate overall timelines, but an
eventual application should take less time than normal in light of
the review.
Write to Joshua Kirby at joshua.kirby@wsj.com;
@joshualeokirby
(END) Dow Jones Newswires
July 20, 2021 11:30 ET (15:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024